Influenza B, Malaysia 2506/04 Infectious Disease
Influenza B, Malaysia 2506/04
Applications
ELISA
Purity
Purified90% (SDS-PAGE). Ultracentrifugation with 10-40% sucrose gradient.
Synonyms
Influenza B; Malaysia 2506/04; Malaysia 2506/04 infectious disease
Purity/Purification
Purified
90% (SDS-PAGE). Ultracentrifugation with 10-40% sucrose gradient.
90% (SDS-PAGE). Ultracentrifugation with 10-40% sucrose gradient.
Form/Format
Supplied as a liquid in 0.05M tris-HCl, pH 8.0, 0.1M sodium chloride, 5mM EDTA, 0.1% sodium azide, 0.005% thimerosal.
Applicable Applications for Influenza B, Malaysia 2506/04 infectious disease
ELISA (EL/EIA)
Application Notes
Suitable for use in serological studies of influenza A virus, and immunogen for antibody production.
Inactivation
Thimerosal and beta propiolactone treatment
Preparation and Storage
May be stored at 4 degree C for short-term only. For long-term storage, aliquot and store at -20 degree C. Aliquots are stable for at least 6 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Related Product Information for Influenza B, Malaysia 2506/04 infectious disease
Influenza B Virus, Strain B/Malaysia/2506/04
Product Categories/Family for Influenza B, Malaysia 2506/04 infectious disease
Similar Products
Product Notes
The Influenza B, Malaysia 2506/04 (Catalog #AAA655226) is an Infectious Disease and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's Influenza B, Malaysia 2506/04 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA). Suitable for use in serological studies of influenza A virus, and immunogen for antibody production. Researchers should empirically determine the suitability of the Influenza B, Malaysia 2506/04 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Influenza B, Malaysia 2506/04, Infectious Disease" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
